Home
About
Overview
Sharing Data
ORCID
Help
History (23)
Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic, randomized clinical trial.
Small-molecule inhibition of the METTL3/METTL14 complex suppresses neuroblastoma tumor growth and promotes differentiation.
The RISE FOR HEALTH study: Methods for in-person musculoskeletal assessment.
The three-dimensional structure of Epstein-Barr virus genome varies by latency type and is regulated by PARP1 enzymatic activity.
Clinical Utility and Benefits of Comprehensive Genomic Profiling in Cancer.
See All 23 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Gordon, Kenneth
One or more keywords matched the following items that are connected to
Gordon, Kenneth
Item Type
Name
Concept
TYK2 Kinase
Academic Article
Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis.
Academic Article
Molecular and clinical effects of selective tyrosine kinase 2 inhibition with deucravacitinib in psoriasis.
Academic Article
Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial.
Search Criteria
TYK2 Kinase